DaVita
DVA
#1616
Rank
A$19.26 B
Marketcap
A$300.22
Share price
0.77%
Change (1 day)
43.12%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

P/S ratio for DaVita (DVA)

P/S ratio as of June 2026 (TTM): 0.9769

According to DaVita's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 12.9. At the end of 2026 the company had a P/S ratio of 0.7462.

P/S ratio history for DaVita from 2001 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20260.746224.34%
20250.6001-39.23%
20240.987625.28%
20230.788336.03%
20220.5795-41.92%
20210.9977-12.36%
20201.1437.3%
20190.829110.43%
20180.7508-38.34%
20171.2231.9%
20160.9231-12.99%
20151.06-16.88%
20141.2811.17%
20131.15-19.89%
20121.4338.39%
20111.040.07%
20101.044.44%
20090.99109.02%
20080.9090-20.73%
20071.15-5.96%
20061.22-31.99%
20051.795.79%
20041.7037.89%
20031.2351.61%
20020.8108-35.37%
20011.25

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Universal Health Services
UHS
0.4925-49.59%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
1.50 54.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
0.7031-28.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
1.00 2.48%๐Ÿ‡บ๐Ÿ‡ธ USA